- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06948123
Myocardial Infarction (Nursing Theory)
The Effect of Nursing Approach Based on MELEIS Transition Theory on Cardiac Quality of Life and Adaptation to Disease in Patients With Acute Myocardial Infarction
The effect of nursing approach based on Meleis's transition theory on cardiac quality of life and adaptation to disease in patients with acute myocardial infarction.
This research was planned with the idea that the approach developed based on Meleis's Transition Theory could facilitate the illness-health transition process in patients, increase their healthy behavioral gains, increase the quality of care, reduce rehospitalizations, reduce the mortality rate due to MI, and contribute to the nursing literature.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
AYDIN/Türkiye
-
Aydın, AYDIN/Türkiye, Turkey, 09100
- Aydin State Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Among the patients who were hospitalized in the Cardiology Clinic of Aydın State Hospital and underwent emergency coronary angiography;
- Those who were 18 years of age and older, diagnosed with MI,
- Underwent coronary angiography for the first time,
- Conscious,
- No verbal communication barrier,
- Able to read and write,
- Had their polyclinic check-ups at the relevant hospital,
- Agreed to participate in the study,
- Had a telephone to communicate,
- Living in Aydın city center and districts were included in the study.
Exclusion Criteria:
- Patients with COPD,
- Chronic renal failure,
- Cancer, arrhythmia,
- Advanced aortic stenosis and pulmonary hypertension,
- Systemic or pulmonary embolism,
- Chronic cognitive and psychiatric diseases,
- Patients scheduled for organ transplantation,
- Ptage 3 and 4 heart failure (according to New York Heart Association standards),
- Patients with a hospital stay longer than 10 days were excluded from the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Theory-based nursing intervention.
This is the group that was trained with educational material prepared by the researcher based on Meleis's Transition Theory.
|
The experimental group was trained with educational material prepared by the researcher using a computer at home for 15 days after hospital discharge.
|
|
Other: Control
The control group was visited at home 15 days after discharge and the scales were applied.
The final scales were applied to the patient who came to the hospital for 3 months.
The patient was told that the study was over and given educational materials.
|
The control group was visited at home 15 days after discharge and the scales were applied.
The final scales were applied to the patient who came to the hospital for 3 months.
The patient was told that the study was over and given educational materials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychosocial Adjustment-Self-Report Measure (PAIS-SR ),
Time Frame: 3 months for each patient.
|
Psychosocial Adjustment-Self-Report Measure: PAIS-SR: This scale assesses psychological adjustment to illness.
Cronbach's alpha coefficient for the overall scale has been reported to be 0.92.
The scale consists of 46 items and seven subscales.
A total score of less than 35 indicates "good psychosocial adjustment," a score between 35 and 51 indicates "moderate psychosocial adjustment," and a score greater than 51 indicates "poor psychosocial adjustment."
|
3 months for each patient.
|
|
Health-related Quality of Life scale (HEART-QOL)
Time Frame: 3 months for each patient.
|
HEART-QOL: A tool developed to measure quality of life specific to heart disease.
The questionnaire is a scale consisting of 27 items and 7-point Likert type responses, and has 3 sub-dimensions: emotional, physical and social.
Scores are calculated by taking the average of the items for each dimension.
Scores range from 1 to 7, with a low score indicating poor quality of life and a high score indicating better quality of life.
|
3 months for each patient.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: RAHŞAN ÇEVİK AKYIL, PROFESSOR, Aydin Adnan Menderes University Faculty of Nursing
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMU-HEM-SZ-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndromes
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceNot yet recruitingAcute Coronary Syndromes | Acute Coronary Syndromes (ACS)France
-
Tongji HospitalRecruiting
-
SUK MIN SEOBoston Scientific Korea Co. LtdRecruitingAcute Coronary Syndromes (ACS)South Korea
-
China National Center for Cardiovascular DiseasesNot yet recruiting
-
Institute of medicine, Maharagjung medical campusCompletedAdherence | Acute Coronary Syndromes (ACS)Nepal
-
Heart Care FoundationDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyNot yet recruitingAcute Coronary Syndromes | Secondary Prevention | LipidsItaly
-
Ceric SàrlEuropean Cardiovascular Research Center; Philips Medical SystemsNot yet recruitingStable Coronary Artery Disease | Acute Coronary Syndromes
-
Shenyang Northern HospitalNot yet recruitingPercutaneous Coronary Intervention | Acute Coronary Syndromes | High Bleeding Risk | Anticoagulant Therapy
-
SUK MIN SEODaewoong Pharmaceutical Co. LTD.RecruitingCoronary Artery Disease (CAD) | Acute Coronary Syndromes (ACS)South Korea
Clinical Trials on Educational intervention
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBacterial Infection | Clostridium DifficileUnited States
-
Universidad de GranadaNot yet recruitingAsthma | Allergy
-
Roswell Park Cancer InstituteCompletedCervical Cancer | Breast CancerUnited States
-
US Department of Veterans AffairsDuke UniversityCompletedAccidental FallsUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Azienda Unita Sanitaria Locale Reggio EmiliaCompletedMelanoma (Skin) | Educational ProblemsItaly
-
Goethe UniversityUnknownHealth Knowledge, Attitudes, PracticeGermany
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedBreast Cancer | LymphedemaUnited States
-
Claudia AristizábalUniversidad Nacional de Colombia; Universidad de Santander; Fundación Universitaria...Enrolling by invitationBurnout, Psychological | CaregiversColombia
-
McGill University Health Centre/Research Institute...University of Manitoba; Sunnybrook Health Sciences Centre; University of Alberta and other collaboratorsCompletedPeptic Ulcer Hemorrhage